FDA NDC Directory · JSON-LD · Markdown

Zeptide Aspart

NDC 87994-013 · DRUG FOR FURTHER PROCESSING · SOLUTION

Labeler / ManufacturerTirzepatide Pharma
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeSOLUTION
Active ingredientsINSULIN ASPART (100 U/1)
Marketing started20260901
Package count1

External sources

Source: openFDA. Public-domain (CC0).